宫颈癌患者治疗前检测血清HPV16E6 mRNA和CK19 mRNA的临床意义

杨琳琳; 王薇; 张磊; 张红平; 杨宏英

宫颈癌患者治疗前检测血清HPV16E6 mRNA和CK19 mRNA的临床意义

昆明医科大学第三附属医院云南省肿瘤医院妇科

基金项目:

基金：云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目 (2013FB168);

计量
- 文章访问数: 1746
- HTML全文浏览量: 605
- PDF下载量: 92
- 被引次数: 0
出版历程
- 收稿日期: 2016-09-20

Clinical Significance of Examination of Pretreatment Peripheral Blood HPV16E6 mRNA and CK19 mRNA in Cervical Cancer Patients

Funds:

基金：云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目 (2013FB168);

摘要

摘要: 目的检测宫颈癌患者治疗前外周血HPV16E6m RNA和CK19m RNA的表达, 探讨其对宫颈癌的诊断意义及其与临床病理的相关性.方法对100例宫颈癌患者行治疗前外周血HPV16E6m RNA及CK19m RNA检测, 以40例健康妇女为对照, 分析其作为诊断参考的特异性和敏感性, 并对两者与宫颈癌临床病理特征的相关性进行分析.结果 HPV16E6m RNA、CK19m RNA检测诊断宫颈癌的特异性均为97.5%.HPV16E6m RNA、CK19m RNA升高用于治疗前诊断的敏感性分别为15%和39%, 两者差异有统计学意义 (P<0.05) .HPV16E6m RNA升高与临床分期 (P=0.012) 、盆腔淋巴结转移 (P=0.026) 相关.CK19m RNA升高与深肌层浸润 (P=0.031) 、盆腔淋巴结转移 (P=0.027) 相关.结论外周血HPV16E6m RNA和CK19m RNA均是宫颈癌微转移有价值的肿瘤标志物;CK19m RNA在作为宫颈癌指标时, 临床诊断价值优于HPV16E6m RNA.
- 宫颈肿瘤 /
- HPV16E6m RNA /
- CK19m RNA /
- 外周血
Abstract: Objective To investigate the significance of pretreatment peripheral blood HPV16E6m RNA and CK19m RNA in diagnosis and their correlations to the clinicopathologic features of cervical carcinoma.Methods One hundred cervical carcinoma patients underwent pretreatment peripheral blood HPV16E6m RNA and CK19m RNA evaluation;40 healthy women were subjected as control.The specificity and sensitivity of HPV16E6m RNA and CK19m RNA as diagnostic indexes were analyzed; their correlations to clinicopathologic features were investigated.Results The specificity of HPV16E6m RNA and CK19m RNA in the diagnosis of cervical cancer were 97.5%.The sensitivity of HPV16E6m RNA and CK19m RNA in the diagnosis of pre treatment were 15% and39%, respectively and the difference was statistically significant (P <0.05) .HPV16E6m RNA elevation was associated with clinical stage (P= 0.012) and pelvic lymph node metastasis (P=0.026) . CK19m RNA was associated with deep muscular invasion (P=0.031) and pelvic lymph node metastasis (P=0.027) .Conclusion Peripheral blood HPV16E6m RNA and CK19m RNA are the valuable tumor markers of cervical cancer.The value of CK19m RNA in the diagnosis of cervical cancer is better than that of HPV16E6m RNA.
- Cervical neoplasm /
- HPV16E6m RNA /
- CK19m RNA /
- Peripheral blood

HTML全文

参考文献(15)

[1]	[1]QMICHOU Z, KHYATTI M, BERRAHO M, et al.Analysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women[J].BMC Infect Dis, 2013, 13 (8) :378.
[2]	[2]SHI Y l, LI L, HU Z, et al.A genome-wide association study identifies two new cervical cancer susceptibility loci at4q12 and 17q12[J].Nat Genet, 2013, 45 (8) :918-922.
[3]	[3]JIANG B, XUE M.Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells[J].Genet Mol Res, 2015, 14 (3) :10473-10481.
[4]	[4]LEE S J, LEE A W, KANG C S, et al.Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-Positive cervical cytology[J].Int J Med Sci, 2014, 11 (1) :80-86.
[5]	[5]TORTORA M, ANNUNZIATA C, LIGUORI G, et al.Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancer[J].Infect Agent Cancer, 2016, 11 (1) :1-7.
[6]	[6]ZHAO S, YANG H, ZHANG M, et al.Circulating tumor cells (CTCs) detected by triple-marker Ep CAM, CK19, and h MAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients[J].Cell Biochem Biophys, 2013, 65 (2) :263-273.
[7]	[7]SUN D W, ZHANG Y Y, SUN X D, et al.Prognostic value of cytokeratin 19 in hepatocellular carcinoma:A meta-analysis[J].Clin Chim Acta, 2015, 25 (8) :161-169.
[8]	[8]ZHANG X, CHEN S B, CHEN J X, et al.CK19 m RNA expression in the bone marrow of patients with esophageal squamous cell carcinoma and its clinical significance[J].Dis Esophagus, 2010, 23 (5) :437-443.
[9]	[9]YOSHIDA K, SATO K, TONOGI M, et al.Expression of Cytokeratin 14 and 19 in Process of Oral Carcinogenesis[J].Bull Tokyo Dent Coll, 2015, 56 (2) :105-111.
[10]	[10]LIU Z, YU P, XIONG Y, et al.Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma[J].Int J Clin Exp Med, 2015, 8 (3) :4369-4374.
[11]	[11]ZHOU L, ZHANG H, HUANG C, et al.Expression of Daxx and HPV16 E6 and its significance in cervical lesions[J].Zhonghua Yi Xue Za Zhi, 2015, 95 (37) :3050-3053.
[12]	[12]YANG X, LU L.Expression of HPV-16 E6 protein and p53 inactivation increases the uterine cervical cancer invasion[J].Drug Res, 2015, 65 (2) :70-73.
[13]	[13]OKAMOTO S, NIIKURA H, NAKABAYASHI K, et al.Detection of sentinel lymph node metastases in?cervical cancer:assessment of KRT19 m RNA in the one-step nucleic acid amplification (OSNA) method[J].Gynecol Oncol, 2013, 130 (3) :530-536.
[14]	[14]ZHANG F, LIU D, LIN B, et al.Expression of high-risk HPV DNA and CK19 in pelvic lymph nodes in stage Ia-IIa cervical cancer and their clinical value[J].Oncol Rep, 2012, 27 (6) :1801-1806.
[15]	[15]REN C, HAN C, FU D, et al.Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy[J].Int J Cance, 2016, 138 (7) :1586-1600.

相关文章(20)

[1]	谭博文, 梁云, 陈环, 雷毅, 王昱涵, 田衍. 术前外周血炎性指标联合肿瘤标记物对可切除结肠癌患者的预后价值, 昆明医科大学学报.
[2]	崔湘杰, 陶玉芬, 朱兰芳, 姚宇峰, 史荔. HPV16 E6、E7多表位DNA疫苗的构建及免疫效果评估, 昆明医科大学学报.
[3]	肖金宝, 赵骏达, 马俊旗. 下调HPV16 E6/E7表达宫颈癌细胞Siha上清液代谢组学, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240104
[4]	郭方圆, 李文亮, 徐凡, 魏向群. 非编码RNA 在宫颈癌组织中的表达及临床意义, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220527
[5]	陈红兰, 吴怡, 胡滔, 王玉明. 外周血G6PD活性检测对于感染高危型人乳头瘤病毒宫颈癌患者的诊断预后价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220203
[6]	杨琳琳, 尹春梅, 张磊, 王薇, 赵凌锋, 杨钰叠, 赵赫, 刘莹. HPV16E6与吲哚胺2，3-二氧化酶在宫颈病变组织中的表达, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20201219
[7]	李珲, 平秦榕, 史云强, 王春晖, 杨洋, 胡礼炳, 毕晓方, 李健, 钟一鸣. 外周血CTCs与前列腺癌临床特征的相关性, 昆明医科大学学报.
[8]	孙春意, 许长俊, 黄娅娟, 卿清, 李岱株, 刘洋. 两种不同杂交捕获定量技术对意义不明的非典型鳞状细胞的分流价值, 昆明医科大学学报.
[9]	胡滔, 洪颖, 陈红兰, 常业飞, 姜水, 习杨彦彬, 檀雅欣, 李珊, 刘光彩, 吴晓虹. miR-1对HR HPV 16~+/18~+宫颈癌细胞周期相关蛋白的调控, 昆明医科大学学报.
[10]	严勇, 孙洵, 李岗, 郑昕, 马绍翔, 李勇, 赵润恒, 王珂. 膀胱癌患者外周血循环肿瘤细胞中Survivin的表达, 昆明医科大学学报.
[11]	李鹏. 门静脉与外周血液胰岛素和C肽浓度的差异性, 昆明医科大学学报.
[12]	阿永俊. 肝衰竭患者MARS人工肝治疗前后不同疗效组外周血TNF-αmRNA和IL-6 mRNA的表达, 昆明医科大学学报.
[13]	王洋. RNA干扰CCR7表达在肿瘤转移治疗中的作用, 昆明医科大学学报.
[14]	陈晓群. 胃癌患者外周血血小板膜糖蛋白水平变化及影响因素分析, 昆明医科大学学报.
[15]	李文亮. TCRγδ/δ2在结直肠癌患者外周血和肿瘤组织中的表达相关性, 昆明医科大学学报.
[16]	魏向群. 早期宫颈癌患者术前外周血CK19 mRNA的检测及其临床意义, 昆明医科大学学报.
[17]	魏向群. 联合检测外周血 CK19和SCCAg mRNA对早期宫颈癌患者微转移的诊断价值, 昆明医科大学学报.
[18]	周石桥. HPLC法间接测定肿瘤患者外周血DPD的活性, 昆明医科大学学报.
[19]	. HPLC法测定肿瘤患者外周血5-FU血药浓度, 昆明医科大学学报.
[20]	. 人乳头状瘤病毒16型E6基因短发夹结构RNA慢病毒载体的构建及鉴定, 昆明医科大学学报.